- Report
- October 2023
- 189 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 176 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 83 Pages
India
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 172 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 73 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 160 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- March 2024
- 101 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- March 2024
- 114 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- November 2023
- 280 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- September 2023
- 331 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- October 2023
- 90 Pages
United Kingdom
From €3185EUR$3,350USD£2,675GBP
- Report
- April 2020
- 80 Pages
United States
From €2567EUR$2,700USD£2,156GBP
- Report
- August 2022
- 245 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- July 2022
- 209 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- April 2022
- 295 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- August 2023
- 145 Pages
Global
From €2995EUR$3,150USD£2,516GBP

Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It is a major public health concern, particularly in developing countries, and is the leading cause of death from a single infectious agent. TB is typically diagnosed through a combination of clinical symptoms, chest X-rays, and laboratory tests. Infectious disease testing for TB is used to detect the presence of the bacteria in a patient's sample. Tests may include sputum smear microscopy, culture, and nucleic acid amplification tests.
The TB testing market is expected to grow due to increasing prevalence of TB, rising awareness of TB diagnosis, and technological advancements in TB testing. The market is segmented by product type, end user, and geography.
Companies in the TB testing market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more